Carboplatin plus weekly paclitaxel treatment in non-small cell lung cancer patients with interstitial lung disease.

@article{Shukuya2010CarboplatinPW,
  title={Carboplatin plus weekly paclitaxel treatment in non-small cell lung cancer patients with interstitial lung disease.},
  author={Takehito Shukuya and Toshiji Ishiwata and Motohiko Hara and Koichiro Muraki and Rina Shibayama and Ryo Koyama and Kota Takahashi},
  journal={Anticancer research},
  year={2010},
  volume={30 10},
  pages={4357-61}
}
BACKGROUND Since advanced non-small cell lung cancer (NSCLC) patients with the interstitial lung disease (ILD) have been excluded from clinical trials, it is uncertain whether chemotherapy really provides a benefit to these patients. PATIENTS AND METHODS Fifteen advanced NSCLC patients with ILD that was detected on the chest X-rays were enrolled in this study. Carboplatin plus paclitaxel was administered by two methods (method A or method B). Method A: Carboplatin (AUC 6, day 1) and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 11 references

Phase II trial of weekly paclitaxel in previously untreated advanced non - small cell lung cancer

  • Y Kawasaki, M Yamamoto, +7 authors E Shimizu
  • Oncology
  • 2003

Similar Papers

Loading similar papers…